Dr. Robert Cavaliere, MD

Dr. Cavaliere practices at Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health.

Dr. Cavaliere's NPI, 1730263096, was assigned on October 24, 2006. Dr. Cavaliere graduated from New York Medical College in 1999. Dr. Cavaliere holds Florida license ME125345.

Dr. Cavaliere's primary practice is Baptist Medical Center Jacksonville, at 800 Prudential Dr, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-2000.

Dr. Cavaliere's primary practice is Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health. Dr. Cavaliere is also affiliated with Brooks Rehabilitation Hospital - University Campus. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Cavaliere to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cavaliere practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cavaliere's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cavaliere is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Cavaliere's licenses on file in 3 states: Florida, Ohio and Virginia.

Dmand AI lists encephalopathy, epilepsy, fibromyalgia and chronic pain, mobility impairment, neuropathy and thoracic spine disorders among the conditions Dr. Cavaliere treats.

CMS data shows 790 Medicare services from Dr. Cavaliere across 9 procedure codes in 2024, for 337 Medicare patients. Medicare paid $75,650 for them.

CMS counts 337 Medicare patients who saw Dr. Cavaliere in 2024. The largest group is 65 to 74, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cavaliere's median patient age at 70, with 54% women.

In 2024, Dr. Cavaliere wrote 334 Medicare Part D claims for 111 patients. 91% of them were for generic drugs. CMS names the drug for 221 of them, across 11 drugs with 11 or more claims each, at $303,175 in total drug cost. In 2023, CMS named 293 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Cavaliere for performance year 2024, reported as part of a group. Dr. Cavaliere accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cavaliere as offering telehealth.

Dmand AI links 27 papers to Dr. Cavaliere, published from 2007 to 2021. 2011 was the busiest year, with 2. The most frequent topics are Brain Neoplasms, Glioma and Antineoplastic Agents. Dr. Cavaliere has published most often in Expert Rev Anticancer Ther. Dr. Cavaliere's most frequent co-authors are John C. Grecula, MD, David L. Schiff, MD and Laura Kaye Aguilar, MD, PhD.

Dmand AI links Dr. Cavaliere to 9 clinical trials, 5 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Astrocytoma, Glioblastoma and Brain Neoplasms. Alliance for Clinical Trials in Oncology sponsors the most, 2.

CMS Open Payments shows 103 general payments to Dr. Cavaliere from 10 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 48% of the total. Novocure Inc. paid the most, $28,680.

Dmand AI lists 1 award for Dr. Cavaliere, most recently CMS Stage 1 EHR in 2013.

Dr. Cavaliere graduated from New York Medical College in 1999.

Dr. Cavaliere is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.